Browse studies
Find your next paid study
159 recruiting studies matching your filters
Observational
Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer
The goal of this clinical trial is to use urine tumor DNA (utDNA) as an indicator for non-muscle invasive bladder cancer to identify patients suitable for less…
Non-muscle Invasive Bladder Cancer (NMIBC)
Estimated
~$10 – $6,250
Lahey ClinicNCT07187063
Phase 1
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
A Phase 1 dose-escalation study designed to evaluate the safety, tolerability, and preliminary efficacy of anito-cel in subjects with generalized myasthenia gr…
Muscular DiseasesNeuromuscular ManifestationsAutoimmune+4 more
Estimated
~$10 – $8,750
Arcellx, Inc.NCT06626919
Phase 1
Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Bladder Preservation in Patients With MIBC (RAD-SG).
The purpose of this study is to examine the safety and tolerability of treatment with concurrent Sacituzumab Govitecan (SG) and adaptive radiation therapy. The…
Localized Muscle Invasive Bladder Urothelial CarcinomaMuscle-Invasive Bladder Carcinoma
Estimated
~$10 – $7,500
Shilpa Gupta, MDNCT05833867